Alonso-Curbelo et al. (2014) further found reduced tumor volume after Rab7 shRNA treatment, again with much more prominent effects in UACC-62 (high MITF) as compared to SK-MEL-103 or SK-MEL-147 (low MITF)9. This evidence concerns the gene RAB7A and neoplasm.